DVAX
Dynavax Technologies Corporation · Healthcare · Drug Manufacturers - Specialty & Generic
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +3.9% · nuevas posiciones netas 0.0% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q4 2025 | 103 | +2 | 73.01M | $1.12B | +2 | n/a |
| Q3 2025 | 20 | +2 | 53.43M | $530.60M | +2 | n/a |
| Q2 2025 | 15 | 0 | 45.98M | $456.16M | +1 | −1 |
| Q1 2025 | 12 | 0 | 18.90M | $245.13M | +1 | −1 |
| Q4 2024 | 12 | +1 | 18.18M | $232.22M | +1 | n/a |
| Q3 2024 | 10 | -1 | 11.01M | $122.60M | +1 | −2 |
| Q2 2024 | 11 | n/a | 10.39M | $116.72M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 6.79M | -12.9% | $88.07M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 3.07M | +2.4% | $39.77M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Renaissance Technologies ✦ | 2.71M | +14.9% | $35.09M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 2.49M | +29.6% | $32.25M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | Two Sigma Investments ✦ | 1.32M | +51.9% | $17.07M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Marshall Wace ✦ | 875.86K | Nuevo | $11.36M | 0.0% | New | 1 | SEC ↗ ×2 |
| 7 | Fisher Asset Management ✦ | 622.05K | -52.1% | $8.07M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 602.98K | +12220.9% | $7.82M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 9 | Millennium Management ✦ | 226.51K | +24.3% | $2.94M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 96.56K | +10.4% | $1.25M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 11 | Wellington Management ✦ | 56.72K | -5.1% | $735,607 | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 12 | Gotham Asset Management ✦ | 53.70K | +281.8% | $696,463 | 0.0% | ▲ Add | 4 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Marshall Wace | $11.36M | 0.0% |
Posición cerrada
| Norges Bank | $7.76M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 6 acciones, $93 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.